The PERCEPTIONS study surveyed U.S. adults who had recently started tirzepatide for weight management (n = 518) [1]. Separate interviews about taking GLP-1 drugs explore how people describe living with treatment. This survey focused on reasons for starting and what got in the way.
What made people want to start?
Respondents commonly mentioned health and well-being (83.8%), physical function (58.3%) and confidence or appearance outside work (51.4%). The survey was completed about 26 days after the first dose on average [1].
What got in the way?
Insurance coverage concerned 90% of participants, and medication cost concerned 57.7%. The companion report on employer coverage for obesity medication explores coverage among workers. Both reports describe people who had already started treatment.
Their answers cannot establish how often coverage or cost stops someone from starting treatment.